2018
DOI: 10.26717/bjstr.2018.09.001806
|View full text |Cite
|
Sign up to set email alerts
|

Wireless Peripheral Nerve Stimulation in the Management of Debilitating Extremity Pain from Meralgia Paresthetica and Complex Regional Pain Syndrome: Report of Two Case Illustrations

Abstract: Chronic intractable pain is one of the most common symptoms necessitating a visit to the medical practitioner [1] and also a leading cause for opioid consumption. SCS has been a time-tested neuromodulation therapy with increasing indications to manage refractory pain [2]. Traditional PNS equipment utilizes the SCS device that has all its components to be implanted inside the patient

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 10 publications
0
2
0
Order By: Relevance
“…65 More recently, a case report described the novel use of a PNS implanted along the course of the LFCN in a patient with severe refractory MP. 66 The implanted device resulted in immediate pain relief that was sustained at a 3-month follow-up evaluation. 66 The use of an SCS for the treatment of meralgia paresthetica has only been reported once in the literature.…”
Section: Treatmentmentioning
confidence: 92%
See 1 more Smart Citation
“…65 More recently, a case report described the novel use of a PNS implanted along the course of the LFCN in a patient with severe refractory MP. 66 The implanted device resulted in immediate pain relief that was sustained at a 3-month follow-up evaluation. 66 The use of an SCS for the treatment of meralgia paresthetica has only been reported once in the literature.…”
Section: Treatmentmentioning
confidence: 92%
“…66 The implanted device resulted in immediate pain relief that was sustained at a 3-month follow-up evaluation. 66 The use of an SCS for the treatment of meralgia paresthetica has only been reported once in the literature. 67,68 After the implantation of the device, the patient reported nearly complete pain relief at 8 months with no reported adverse effects.…”
Section: Treatmentmentioning
confidence: 92%